(NaturalNews) A revolutionary, one-stop-shop resource for learning the full truth about vaccines and how to prevent, treat and reverse infectious disease symptoms naturally without drugs or jabs is now available online, 24 hours a day, seven days a week, through the amazing Vaccine…
(NaturalNews) Fruits, vegetables, nuts, and even dark chocolate are without question staples of a healthy diet. But did you know that some of these highly nutritious foods might be poisoning your body and sending your defense mechanisms into chronic overdrive? Nature’s weapon of choice…
(NaturalNews) During and after the Vietnam War, manufacturers of the infamous chemical weapon “Agent Orange” claimed it was “completely safe” for human exposure. Thousands of war veterans came back to the US after trudging through the chem-laden brush in Vietnam only to find themselves…
(NaturalNews) The world’s great powers, over the past 100 years, have grown more liberal in their societies and socialist in their economies.Of course, plenty of people will dispute that, but facts are, as they say, facts, and no matter how many times you shout down the truth…
WASHINGTON (AP) — President Barack Obama says he’s ready to sign good bipartisan legislation to fix Medicare’s doctor payment problem, without endorsing any specific legislation.
(Reuters) – U.S. health regulators on Wednesday approved Regeneron Pharmaceuticals Inc’s big-selling eye drug Eylea to treat diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in adults. The Food and Drug Administration decision marked the fourth approval for Eylea, an injectable medicine sold in partnership with French drugmaker Sanofi. “Today’s approval gives patients with diabetic retinopathy and diabetic macular edema another therapy to treat
The global pharmaceutical industry is make huge investments in treatments for rare diseases, which once drew little interest from major drugmakers. A look at some key statistics on rare diseases:
TRENTON, N.J. (AP) — The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits.
by Gabriel R. Sanchez, Francisco I. Pedraza and Edward D. Vargas As President Obama’s signature domestic policy achievement, the Affordable Care Act (ACA) faces another test in the upcoming Supreme Court case King v. Burwell. As we await a decision that has huge implications for Obamacare, we take a closer look at whether the ACA has been…
WASHINGTON (Reuters) – The U.S. Consumer Product Safety Commission said on Wednesday it was investigating laminates used by Lumber Liquidators Holdings Inc, after reports that its products contained too-high levels of formaldehyde. Commission Chairman Elliot Kaye said the regulator would determine in the coming months whether the products were harmful to human health. He said the company had been cooperative so far with the agency’s probe. (Reporting by Emily Stephenson;
